True North Advisors’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$240K 201
2022
Q4
$240K Buy
+600
New +$240K 0.08% 153